Study on active ingredients and molecular mechanism of keluoxin in treatment of diabetic kidney disease based on network pharmacology and molecular docking

ZHAO Huimin, XU Jiahui, CHEN Qingguang, LU Hao

PDF(4608 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(4608 KB)
World Clinical Drug ›› 2023, Vol. 44 ›› Issue (05) : 468-476. DOI: 10.13683/j.wph.2023.05.011
Article

Study on active ingredients and molecular mechanism of keluoxin in treatment of diabetic kidney disease based on network pharmacology and molecular docking

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 44(05): 468-476 https://doi.org/10.13683/j.wph.2023.05.011

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(4608 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉